Nextech Invest
Marco Weibel is the chief financial officer at Nextech Invest Ltd. Prior to joining Nextech in 2015, Marco was the chief financial officer of the vision4health group. He also previously held financial leadership roles at Wyeth, Pfizer (NYSE: PFE) and Alcon (NYSE: ALC). He holds a postgraduate degree in leadership and management from the Institute of Advanced Studies Lucerne, Switzerland and a B.A. from the University of Applied Sciences in Economics and Business Administration in Lucerne, Switzerland. He is a Swiss certified expert in accounting and controlling.
This person is not in any offices
Nextech Invest
Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland. They focus almost exclusively on oncology therapeutics, and on helping to drive value creation for their portfolio companies. They invest in the most promising drug discovery companies with the potential to create multiple medicines. Their portfolio is focused throughout the US and Europe with investments from company inceptions to crossover rounds.